+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Angina Pectoris Drugs Market - Global Forecast 2026-2032- Product Image
Angina Pectoris Drugs Market - Global Forecast 2026-2032- Product Image
New

Angina Pectoris Drugs Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715602
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Angina Pectoris Drugs Market is experiencing dynamic change, driven by evolving clinical practices, regulatory shifts, and supply chain innovation. Senior decision-makers require actionable insights to maintain competitiveness and ensure continuity in this complex therapeutic landscape.

Market Snapshot

The angina pectoris drugs market grew from USD 1.27 billion in 2025 to USD 1.32 billion in 2026 and is projected to reach USD 1.86 billion by 2032, advancing at a compound annual growth rate (CAGR) of 5.59%. This reflects an industry adapting to shifting procurement strategies, digital disruption, and continuity demands—key themes influencing decision-making for organizations targeting sustained market access.

Scope & Segmentation

This report offers a comprehensive orientation to clinical, commercial, and supply factors shaping angina therapeutics. It dissects:

  • Drug Classes: ACE inhibitors, antiplatelet agents, beta blockers, calcium channel blockers, nitrates—evaluated for clinical use and market relevance.
  • Dosage Forms: Capsules, injections, patches, tablets—analyzed for adoption by care setting and impact on patient adherence.
  • Administration Routes: Injectable (intramuscular, intravenous), oral (controlled-release, immediate-release), sublingual (sprays, tablets), transdermal—considered for acute and maintenance therapy.
  • Distribution Channels: Hospital pharmacies, online (B2B/B2C) pharmacies, retail pharmacies—addressing differentiated procurement and access models.
  • End-User Settings: Clinics, homecare (caregiver- and patient-led), private and public hospitals—explored to inform product positioning and education strategies.
  • Regional Analysis: Americas, Europe, Middle East & Africa, Asia-Pacific—highlighting divergent regulatory frameworks and clinical practice patterns.
  • Technology and Digital Trends: Integration of digital health tools, adherence monitoring, e-prescriptions, and omnichannel supply innovation.

Key Takeaways

  • Incremental formulation and delivery innovations improve adherence and acute symptom management, influencing portfolio strategies for both originators and generic manufacturers.
  • Digital pharmacy and integrated hospital procurement platforms are reshaping channel economics—favoring suppliers able to provide digital support, traceable supply chains, and flexible product packaging.
  • Regional manufacturing and strategic partnerships are expanding as organizations mitigate trade and geopolitical risks, seeking operational agility and secure sourcing of active ingredients.
  • Therapeutic differentiation now coexists with operational excellence; manufacturers must align evidence generation with payer and provider priorities focused on real-world outcomes and supply continuity.
  • Customization of dosage forms for acute versus maintenance treatment and end-user settings enables improved patient access and targeted product strategies across geographies.
  • Payer, formulary, and hospital committee decision criteria increasingly hinge on supply resilience, cost efficiency, and proven product interchangeability in a tariff-influenced environment.

Tariff Impact

Recent tariff policies have prompted manufacturers to recalibrate supply strategies—accelerating trends in reshoring, multi-sourcing, and contractual redesign. Procurement teams now emphasize supplier diversification, long-term agreements with contingency clauses, and ongoing regulatory compliance. These adjustments are critical to minimizing clinical disruption, ensuring product availability, and maintaining financial stability for all stakeholders in the angina drugs market.

Methodology & Data Sources

Insights in this report were synthesized through qualitative expert interviews with clinicians, procurement specialists, and supply chain managers, as well as reviews of current regulatory guidance, product labeling, and clinical literature. The primary focus was triangulating operational realities and clinical priorities to provide a practice-oriented analysis. Confidentiality and strict adherence to observational verification underpin the presented findings.

Why This Report Matters

  • Offers a holistic understanding of market levers—optimizing sourcing, product development, and channel strategies specific to angina therapeutics.
  • Supports tactical and strategic planning, helping organizations adapt to evolving compliance, procurement, and clinical requirements across regions.
  • Provides clarity for senior executives managing cross-functional teams by translating fast-changing regulatory and operational shifts into concrete actions for sustained market access.

Conclusion

The angina pectoris drugs market is defined by clinical tradition balanced with operational innovation. Aligning therapeutic value with resilient supply and agile execution empowers stakeholders to maintain patient access and competitive advantage as the landscape evolves.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Angina Pectoris Drugs Market, by Drug Class
8.1. Ace Inhibitors
8.1.1. Enalapril
8.1.2. Lisinopril
8.2. Antiplatelet Agents
8.2.1. Aspirin
8.2.2. P2Y12 Inhibitors
8.3. Beta Blockers
8.3.1. Nonselective
8.3.2. Selective
8.4. Calcium Channel Blockers
8.4.1. Dihydropyridines
8.4.2. Nondihydropyridines
8.5. Nitrates
8.5.1. Long Acting
8.5.2. Short Acting
9. Angina Pectoris Drugs Market, by Dosage Form
9.1. Capsule
9.2. Injection
9.3. Patch
9.4. Tablet
10. Angina Pectoris Drugs Market, by Route Of Administration
10.1. Injectable
10.1.1. Intramuscular
10.1.2. Intravenous
10.2. Oral
10.2.1. Controlled Release
10.2.2. Immediate Release
10.3. Sublingual
10.3.1. Spray
10.3.2. Tablet
10.4. Transdermal
10.4.1. Reservoir
10.4.2. Single Layer
11. Angina Pectoris Drugs Market, by Distribution Channel
11.1. Hospital Pharmacies
11.2. Online Pharmacies
11.2.1. Business To Business
11.2.2. Business To Consumer
11.3. Retail Pharmacies
12. Angina Pectoris Drugs Market, by End User
12.1. Clinics
12.1.1. Private Clinics
12.1.2. Public Clinics
12.2. Homecare
12.2.1. Caregiver Administered
12.2.2. Self Administered
12.3. Hospitals
12.3.1. Private Hospitals
12.3.2. Public Hospitals
13. Angina Pectoris Drugs Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Angina Pectoris Drugs Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Angina Pectoris Drugs Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Angina Pectoris Drugs Market
17. China Angina Pectoris Drugs Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. Amgen Inc.
18.7. AstraZeneca PLC
18.8. Aurobindo Pharma Limited
18.9. Bayer AG
18.10. Boehringer Ingelheim International GmbH
18.11. Bristol-Myers Squibb Company
18.12. Daiichi Sankyo Company Limited
18.13. Dr. Reddy's Laboratories Ltd.
18.14. Eli Lilly and Company
18.15. Gilead Sciences Inc.
18.16. GlaxoSmithKline PLC
18.17. Hikma Pharmaceuticals PLC
18.18. Johnson & Johnson
18.19. Merck & Co. Inc.
18.20. Mylan N.V.
18.21. Novartis AG
18.22. Pfizer Inc.
18.23. Regeneron Pharmaceuticals Inc.
18.24. Roche Holding AG
18.25. Sanofi S.A.
18.26. Sun Pharmaceutical Industries Ltd.
18.27. Takeda Pharmaceutical Company Limited
18.28. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANGINA PECTORIS DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANGINA PECTORIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ANGINA PECTORIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ENALAPRIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ENALAPRIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ENALAPRIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LISINOPRIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LISINOPRIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LISINOPRIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ASPIRIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ASPIRIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY P2Y12 INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY P2Y12 INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY P2Y12 INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONSELECTIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONSELECTIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONSELECTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELECTIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELECTIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELECTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DIHYDROPYRIDINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DIHYDROPYRIDINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DIHYDROPYRIDINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONDIHYDROPYRIDINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONDIHYDROPYRIDINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NONDIHYDROPYRIDINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LONG ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LONG ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY LONG ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SHORT ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SHORT ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SHORT ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CONTROLLED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CONTROLLED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY IMMEDIATE RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY IMMEDIATE RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RESERVOIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RESERVOIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SINGLE LAYER, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SINGLE LAYER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SINGLE LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO BUSINESS, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO BUSINESS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO BUSINESS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO CONSUMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO CONSUMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BUSINESS TO CONSUMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAREGIVER ADMINISTERED, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAREGIVER ADMINISTERED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CAREGIVER ADMINISTERED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELF ADMINISTERED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SELF ADMINISTERED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 158. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 159. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2032 (USD MILLION)
TABLE 160. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2032 (USD MILLION)
TABLE 161. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2032 (USD MILLION)
TABLE 162. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2032 (USD MILLION)
TABLE 163. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 164. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 165. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 177. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 178. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2032 (USD MILLION)
TABLE 179. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2032 (USD MILLION)
TABLE 180. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2032 (USD MILLION)
TABLE 181. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 194. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 196. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 197. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2032 (USD MILLION)
TABLE 198. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2032 (USD MILLION)
TABLE 199. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
TABLE 212. LATIN AMERICA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2032 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2032 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2032 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2032 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2032 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 232. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 233. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 234. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 235. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2032 (USD MILLION)
TABLE 236. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2032 (USD MILLION)
TABLE 237. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2032 (USD MILLION)
TABLE 238. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2032 (USD MILLION)
TABLE 239. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 240. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 241. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 242. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 243. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 244. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2032 (USD MILLION)
TABLE 245. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 247. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 249. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
TABLE 250. EUROPE ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 251. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 253. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 254. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2032 (USD MILLION)
TABLE 255. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2032 (USD MILLION)
TABLE 256. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2032 (USD MILLION)
TABLE 257. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2032 (USD MILLION)
TABLE 258. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 259. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 260. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 261. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 263. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2032 (USD MILLION)
TABLE 264. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 265. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 266. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 268. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
TABLE 269. MIDDLE EAST ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 270. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 272. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 273. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2032 (USD MILLION)
TABLE 274. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2032 (USD MILLION)
TABLE 275. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2032 (USD MILLION)
TABLE 276. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2032 (USD MILLION)
TABLE 277. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 278. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 279. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 280. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 281. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 282. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2032 (USD MILLION)
TABLE 283. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 284. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 285. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 286. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 287. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
TABLE 288. AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 289. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 290. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 291. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 292. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2032 (USD MILLION)
TABLE 293. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2032 (USD MILLION)
TABLE 294. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2032 (USD MILLION)
TABLE 295. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2032 (USD MILLION)
TABLE 296. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 297. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 298. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 299. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 300. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 301. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2032 (USD MILLION)
TABLE 302. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 303. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 304. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 305. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 306. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
TABLE 307. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 308. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 309. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 310. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 311. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY ACE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 312. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, 2018-2032 (USD MILLION)
TABLE 313. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA BLOCKERS, 2018-2032 (USD MILLION)
TABLE 314. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, 2018-2032 (USD MILLION)
TABLE 315. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, 2018-2032 (USD MILLION)
TABLE 316. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 317. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 318. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 319. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 320. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2032 (USD MILLION)
TABLE 321. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2032 (USD MILLION)
TABLE 322. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 323. ASEAN ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES,

Companies Mentioned

The key companies profiled in this Angina Pectoris Drugs market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Aurobindo Pharma Limited
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company Limited
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.32 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.86 Billion
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Angina Pectoris Drugs Market Report 2025 - Product Image

Angina Pectoris Drugs Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Angina Pectoris Drugs - Global Strategic Business Report - Product Image

Angina Pectoris Drugs - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Angina Pectoris Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Angina Pectoris Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Angina Pectoris Medication Market - Global Forecast to 2030 - Product Image

Angina Pectoris Medication Market - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs - Global Strategic Business Report - Product Image

Ischemic Heart Disease (IHD) Drugs - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From

About the Angina Pectoris Treatment Market

The Angina Pectoris Treatment market within the context of Cardiovascular Drugs is a highly competitive market, with a wide range of products available. These products are used to treat angina pectoris, a type of chest pain caused by reduced blood flow to the heart. Treatment options include lifestyle changes, medications, and surgical procedures. Medications used to treat angina pectoris include nitrates, beta-blockers, calcium channel blockers, and antiplatelet agents. These medications are used to reduce the frequency and severity of angina attacks, as well as to reduce the risk of heart attack and stroke. The Angina Pectoris Treatment market is driven by the increasing prevalence of cardiovascular diseases, the growing elderly population, and the increasing awareness of the importance of preventive healthcare. Some of the major companies in the Angina Pectoris Treatment market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.